MiniValuatorMiniValuator
    估值工具
  • 股票估值
  • AI 分析New
  • 内容
  • 定价
MiniValuatorMiniValuator

极简股票估值工具(DCF & PE),源自我们的投资社区。

工具
DCF 计算器PE 计算器工具对比DCF 估值PE 估值定价
热门股票
AAPL 股票估值MSFT 股票估值GOOGL 股票估值AMZN 股票估值TSLA 股票估值查看全部
学习
DCF 方法论PE 方法论术语表使用指南投资洞察
核心概念
内在价值自由现金流WACC安全边际终值市盈率
社区
关于我们小红书Newsletter
资源
AI Girl Generatorllms.txtllms-full.txt
Built for value investors
© 2024 MiniValuator, All rights reserved
隐私政策服务条款
PE 估值›Healthcare›HUM

Humana Inc. (HUM) 股票估值 — PE 分析

Medical - Healthcare Plans · NYSE

当前价格

$243.12

内在价值

使用下方计算器估算

使用 PE 市盈率计算 HUM 公允价值

对 Humana Inc. 运行 PE 市盈率估值,自动填充盈利数据,可调节目标 PE,即时获得公允价值估算。

公司简介

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

财务指标 — HUM PE 估值数据

Earnings Yield

3.86%

ROE (TTM)

6.2%

基于过去 12 个月的数据,HUM 每股收益为 N/A,市盈率为 N/A。 这些是使用 PE 市盈率方法进行股票估值的关键输入。

常见问题

HUM 的市盈率是多少?

HUM 的过去 12 个月市盈率反映投资者为 Humana Inc. 每一美元收益所支付的价格。该指标在与Medical - Healthcare Plans同类公司和公司自身历史区间对比时最有意义。

基于市盈率,HUM 被高估了吗?

HUM 是否被高估取决于将其市盈率与Medical - Healthcare Plans同类公司、历史均值和增长预期比较。高于行业均值的 PE 可能暗示高估,但高增长公司通常有更高的估值倍数。建议配合 DCF 模型获得更完整的判断。

如何使用市盈率对 HUM 进行估值?

对 Humana Inc. 使用 PE 估值的步骤:(1) 将当前市盈率与Medical - Healthcare Plans中位数对比评估相对定价,(2) 查看 PEG 比率以调整增长预期,(3) 参考 5 年 PE 历史区间判断当前位置,(4) 用目标 PE 乘以前瞻 EPS 估算公允价值。这种相对估值方法与 DCF 的绝对估值互为补充。

HUM 的 PEG 比率是多少?

PEG 比率将市盈率除以预期盈利增速,提供增长调整后的估值指标。PEG 低于 1.0 可能表明相对于增长被低估,高于 2.0 可能暗示高估。PEG 对盈利增长稳定可预测的公司最为可靠。

对 HUM 应该使用 PE 还是 DCF 估值?

PE 市盈率给出快速的相对定价——HUM 相对于Medical - Healthcare Plans同类的估值水平。DCF 基于预期自由现金流提供绝对价值。建议用 PE 做快速筛选,用 DCF 做深度分析。两种方法各有盲区:PE 忽略了资本结构和现金流质量,DCF 则对增长率和折现率假设非常敏感。

了解更多

  • — AI 生成的竞争护城河与投资风险深度分析
  • — 通过折现现金流分析计算内在价值
  • — PE 市盈率估值分步指南
  • — 折现现金流分析指南
  • — 理解市盈率
  • — 如何评估股票公允价值

相关 PE 估值

打开 HUM PE 计算器
或试试 HUM DCF 估值 →
HUM AI 护城河与风险分析 →
查看 HUM DCF 估值 →
PE 方法论
DCF 方法论
PE 市盈率
内在价值
UNH查看 PE
JNJ查看 PE
LLY查看 PE
ABBV查看 PE
MRK查看 PE
TMO查看 PE
ABT查看 PE
DHR查看 PE